🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are urged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Some professionals stated the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Content Elimination

According to the social media company, the platform has taken down problematic material and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Online Trading Operations

Research also discovered communities with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.

Within minutes of entering one group, a vendor shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.

Item Details and Pricing

Within these communities, posts show dark colored packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to possibly significant health risks”.